{
    "id": 20807,
    "fullName": "CDK7 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CDK7 positive indicates the presence of the CDK7 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1022,
        "geneSymbol": "CDK7",
        "terms": [
            "CDK7",
            "CAK",
            "CAK1",
            "CDKN7",
            "HCAK",
            "MO15",
            "p39MO15",
            "STK1"
        ]
    },
    "variant": "positive",
    "createDate": "04/07/2016",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8541,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, THZ1 inhibited CDK7 signaling and survival in triple-receptor negative breast cancer cell lines in culture, resulted in tumor regression in both cell line and patient-derived xenograft models (PMID: 26406377).",
            "molecularProfile": {
                "id": 21299,
                "profileName": "CDK7 positive"
            },
            "therapy": {
                "id": 3908,
                "therapyName": "THZ1",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6684,
                    "pubMedId": 26406377,
                    "title": "CDK7-dependent transcriptional addiction in triple-negative breast cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26406377"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16509,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SY-5609 selectively inhibited CDK7, resulted in growth inhibition in culture and anti-tumor activity in cell line xenograft and patient-derived xenograft (PDX) models of a panel of tumors (AACR, Apr 2019, Session PO.MCB06.02, 4421/15).",
            "molecularProfile": {
                "id": 21299,
                "profileName": "CDK7 positive"
            },
            "therapy": {
                "id": 8094,
                "therapyName": "SY-5609",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14598,
                    "pubMedId": null,
                    "title": "SY-5609, an orally available selective CDK7 inhibitor demonstrates broad anti-tumor activity in vivo",
                    "url": "https://www.abstractsonline.com/pp8/#!/6812/presentation/5915"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5608,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, THZ1 inhibited CDK7 activity and resulted in reduced cell viability in T-cell acute lymphocytic leukemia cell lines in culture (PMID: 25043025).",
            "molecularProfile": {
                "id": 21299,
                "profileName": "CDK7 positive"
            },
            "therapy": {
                "id": 3908,
                "therapyName": "THZ1",
                "synonyms": null
            },
            "indication": {
                "id": 5602,
                "name": "T-cell adult acute lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5124,
                    "pubMedId": 25043025,
                    "title": "Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25043025"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 21299,
            "profileName": "CDK7 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}